亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Glucagon-Like Peptide 1 Analogues as Adjunctive Therapy for Patients With Type 1 Diabetes: An Updated Systematic Review and Meta-analysis

医学 艾塞那肽 内科学 利拉鲁肽 不利影响 辅助治疗 减肥 2型糖尿病 背景(考古学) 低血糖 优势比 荟萃分析 糖尿病 随机对照试验 内分泌学 胰岛素 肥胖 古生物学 生物
作者
Jeayoung Park,Spyridon Ntelis,Elvina Yunasan,Katherine D. Downton,Terry Cheuk‐Fung Yip,Kashif M. Munir,Nowreen Haq
出处
期刊:The Journal of Clinical Endocrinology and Metabolism [Oxford University Press]
卷期号:109 (1): 279-292 被引量:69
标识
DOI:10.1210/clinem/dgad471
摘要

CONTEXT: Concomitant obesity is common among patients with type 1 diabetes mellitus (T1DM), yet adjunctive therapy options are scarce. OBJECTIVE: We assess the efficacy and adverse outcomes of glucagon-like peptide 1 (GLP-1) analogues when used as adjunctive therapy for T1DM. METHOD: PubMed, EMBASE, Cochrane Central, and Scopus databases were searched for randomized controlled trials up to December 2022. Efficacy outcomes were A1c level, body weight, and total daily insulin (TDI) after ≥12 weeks of GLP-1 therapy. We also assessed 12 different adverse outcomes. Subgroup analysis was done for newly diagnosed or C-peptide positive (C-pos) patients. We report the certainty of evidence based on the GRADE assessment tool. RESULTS: A total of 24 studies using 4 different GLP-1 analogues with a total of 3377 patients were included. Liraglutide had the most substantial evidence with effect sizes on A1c (-0.09%/mg), weight (-2.2 kg/mg), and TDI (-4.32 IU/mg). Liraglutide dose was the greatest predictor of greater average weight loss and TDI decrease but was associated with higher odds of nausea (OR 6.5; 95% CI, 5.0-8.4) and ketosis (OR 1.8; 95% CI, 1.1-2.8). Odds of severe (OR 0.67; 95% CI, 0.43-1.04) or symptomatic hypoglycemia (OR 0.89; 95% CI, 0.53-1.51) were not significantly elevated. Among C-pos patients, greater A1c decrease (-0.51% vs -0.28%) but similar weight loss and TDI were seen. Effect sizes for exenatide were similar, but studies had higher risk of bias and safety data were sparse. CONCLUSION: Our meta-analysis supports therapeutic benefits of liraglutide for patients with T1DM mainly for weight loss and insulin dose reduction. Newly diagnosed or C-pos patients do not appear to experience greater weight loss benefits.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
leoo完成签到,获得积分10
8秒前
腿腿完成签到,获得积分10
10秒前
欢呼的馒头完成签到,获得积分10
23秒前
tigger完成签到 ,获得积分10
30秒前
zilicai的应助被冷阳采纳,获得10
42秒前
59秒前
如意大神完成签到,获得积分10
1分钟前
1分钟前
寒冷的月亮完成签到 ,获得积分10
1分钟前
1分钟前
落后的雪青完成签到,获得积分10
1分钟前
1分钟前
1分钟前
YYY发布了新的文献求助10
1分钟前
Maestro_S的应助被Heaven采纳,获得10
1分钟前
1分钟前
MT完成签到,获得积分10
1分钟前
光亮的成败完成签到,获得积分10
1分钟前
1分钟前
快乐夜阑完成签到,获得积分10
1分钟前
完美世界的应助被Heaven采纳,获得10
1分钟前
1分钟前
Shicheng完成签到,获得积分10
1分钟前
zhiwei完成签到,获得积分10
1分钟前
1分钟前
1分钟前
2分钟前
2分钟前
2分钟前
腼腆的乘云完成签到,获得积分10
2分钟前
Ttimer发布了新的文献求助10
2分钟前
自觉康乃馨完成签到,获得积分10
2分钟前
ZYP完成签到,获得积分10
2分钟前
受伤若男完成签到,获得积分10
2分钟前
3分钟前
拉长的映波完成签到,获得积分10
3分钟前
yoshi发布了新的文献求助10
3分钟前
3分钟前
yoshi完成签到,获得积分10
3分钟前
搜集达人的应助被yoshi采纳,获得10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179920
求助须知:如何正确求助?哪些是违规求助? 9570103
关于积分的说明 21808354
捐赠科研通 7775701
什么是DOI,文献DOI怎么找? 3433193
关于科研通互助平台的介绍 2557347
邀请新用户注册赠送积分活动 2478918